Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UY31303ApriorityCriticalpatent/UY31303A1/en
Publication of UY31303A1publicationCriticalpatent/UY31303A1/en
Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
Compounds derived from substituted pyridazine; hedgehog and smo signaling inhibitors; pharmaceutical composition; and use for the treatment of disorders or syndromes associated with hyperproliferative diseases.
Compounds derived from 2-oxo-2,5-dihydro pyrrole propionamide, glucokinase activators; preparation procedure; pharmaceutical composition comprising said compounds; and its use in the treatment of diabetes mellitus.
DERIVATIVES OF ANILINA-PYRIMIDINE SUBSTITUTED WITH SULFOXIMINE AS INHIBITORS OF CYCLINE DEPENDENT KINASES (CDK), PRODUCTION AND USE OF THE SAME AS MEDICINAL PRODUCTS
Substituted 1,3-dihydro-5-isobenzofurancarbonitrile derivative compounds, selective serotonin reuptake inhibitors; pharmaceutical composition; preparation procedure; Useful in the treatment and / or prevention of premature ejaculation.
Compounds derived from spiro-conjugated pyrazoles, inhibitors of ksp kinesin activity; pharmaceutical composition comprising said compound; and use of the compound for the treatment of proliferative diseases.
Compounds derived from 3- (n-heterocyclyl) -pyrrolidin-phenyloxazolidinones; preparation procedure; pharmaceutical composition; and use of the compound for the treatment of bacterial infections
Compounds derived from 3-cyanopyrrolidine-phenyl-oxazolidinones; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound for the treatment of bacterial infections.
PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ASSOCIATION OF I) CYCLLOBENZAPRINE, II) ACECLOFENACO AND OPTIONALLY III) EXCIPIENTS; AND ITS USE FOR THE TREATMENT OF PAINFUL MUSCLE DISEASES.